The litigators I’ve talked to on the defense side of the securities class action bar have consistently said that getting COVID-related securities claims to stick is going to be a tough haul for their colleagues in the plaintiffs bar.

The argument goes that, in such a rapidly changing environment, it’s tough to prove a company made a false or misleading statement related to COVID’s impact on its business, rather than something that’s proven false by the passage of time. It’s also hard to say when a company improperly withheld vital information from investors about the pandemic, when what we know about the virus’s impact on humans, let alone markets, changes day-to-day.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]